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Cautious apoptosis
t is not easy to convince sympathetic neurons to commit suicide. Potts et al. (page 789) now show that a caspase inhibitor called XIAP acts as a safety brake so that these terminally differentiated cells do not take the death decision too lightly.
Earlier studies established that injection of cytochrome c , which is normally released from mitochondria to activate caspases and thus apoptosis, can kill most cell types but not sympathetic neurons. This resistance can be overcome by coinjection with excess Smac, which shuts down caspase inhibitors including XIAP. Potts et al. now show that cells lacking XIAP no longer need Smac, and succumb to cytochrome c injection alone.
This clean result from a single gene deletion was surprising because there are a number of XIAP-like inhibitors, or IAPs,
I
deleting a hinge between the two helices. This deleted protein can move well in vitro, but is a poor replacement for wild-type gene function in worms. Perhaps this motor is activated too easily, and therefore whizzes out to the axon before it has cargo.
An important question remains: does any kinesin truly operate as a monomer? The sizeable rotation seen in the KIF1A studies (which was proposed to drive monomeric movement) is minimal in Unc104, based on the new structures. But a decisive conclusion may require further experiments. If dimerization is required for movement, then mutations in neck helices that disrupt dimerization should always destroy movement. Many such correlations may be necessary before the monomeric camp gives up its cause.
H1 and H2 form an inhibitory finger in the Unc104 monomer.
that have until now been largely undifferentiated. The entire family of proteins has been plagued by the absence of knockout phenotypes (although their overexpression clearly inhibits apoptosis); this situation has now been rectified for XIAP.
As postmitotic cells that are not easily XIAP levels drop after NGF withdrawal.
replaced, sympathetic neurons must resist most toxic insults without resorting to apoptosis. These insults can breach mitochondria, releasing not only cytochrome c but also Smac. But Potts et al. find that these endogenous levels of Smac are not sufficient to shut off XIAP, unlike the excess injected Smac. Only when survival factors such as NGF are withdrawn do the neurons finally give up the ghost. The mechanism of XIAP downregulation is not yet clear. After NGF withdrawal, XIAP mRNA levels are reduced. But XIAP protein degradation may also occur, as XIAP levels drop more after NGF withdrawal than after a protein synthesis shut-off with cycloheximide. A mystery also surrounds the specificity of the phenotype: both why XIAP is the critical IAP in sympathetic neurons, and why the similar levels of XIAP found in other cell types do not have a similar safety brake effect.
